Halyard Health announced on November 1, 2017 that it is entering into a definitive agreement to sell the Surgical and Infection Prevention business to Owens & Minor. The transaction is subject to regulatory approval and other customary closing conditions and is expected to close in the first quarter of 2018.
This transaction represents a milestone for both our businesses. It accelerates Halyard’s transformation into a leading medical devices company with significant resources to fast-track growth while also giving the S&IP business a solid outlook as part of Owens & Minor – an ideal buyer with the resources to take the business forward.
Halyard will remain a customer-centric culture with a focus on delivering improved healthcare outcomes and economics for customers and patients through innovative product development. We are committed to working with you to help ensure a seamless transition while continuing to meet your evolving needs. Be assured that you will continue to receive the same dedicated service, support and high quality products you have come to expect from us over the years.
We’ll be in touch shortly with information about the transition. In the meantime, please contact us at TransitionQuestions@hyh.com. We appreciate your support and cooperation to make this a smooth transition for all, and I thank you for your continued loyalty and partnership!
Chief Executive Officer